Titan Company’s ₹671 crore Damas credit is non-operational

Titan Company recorded a ₹671 crore non-operational credit in Q2FY27 after reassessing the future payout for Damas and reducing an option liability initially estimated at ₹1,668 crore. The reassessment followed disruption to Damas’s CY26 performance from Middle East geopolitical volatility, and Titan says quarterly adjustments may continue through CY29.

How did the Damas revaluation affect Titan’s Q2FY27 accounts?

Titan recorded a ₹671 crore non-operational credit in its reported financial statements after reducing the fair value of the option liability for the second Damas acquisition tranche. The company says the reduction reflected its current assessment that Damas’s business performance in calendar year 2026, or CY26, has been affected by the volatile geopolitical situation in the Middle East.

The credit is separate from the operating figures presented in Titan’s consolidated business view. Titan explicitly says its Q2FY27 company-level income of ₹20,533 crore and earnings before interest and tax, or EBIT, of ₹2,865 crore exclude the liability relating to the Damas acquisition. That distinction means the ₹671 crore accounting credit should not be read as income generated by the jewellery, watches, EyeCare or other operating businesses.

Titan’s Q2FY27 operating view showed income rising 25.1% year on year from ₹16,407 crore, while EBIT increased 59.3% from ₹1,799 crore. The EBIT margin rose to 14.0% from 11.0%, but those stated comparisons exclude the Damas acquisition liability and therefore do not incorporate the ₹671 crore revaluation credit.

What Damas payment structure is Titan revaluing?

Titan acquired the first 67% equity stake in Damas in Q4FY26 for ₹1,190 crore, while the remaining 33% stake is tied to milestones and would be completed after CY29. This two-tranche structure is why Titan has an option liability in addition to the consideration paid for the initial stake.

At the acquisition date, Titan accounted for an estimated ₹1,668 crore option liability for the second tranche under applicable accounting standards. The future value is not fixed in the presentation: it is linked to Damas milestones and depends on the probable business-performance assessment over the four-year CY26-to-CY29 period.

Indian Accounting Standard 109, or Ind-AS 109, requires Titan to fair-value that option liability at every quarter-end. Titan therefore lowered the value by ₹671 crore in Q2FY27 based on its current performance assessment, creating the matching credit in reported accounts rather than changing the operating result of its jewellery business.

The accounting treatment also places Damas within Titan’s jewellery reporting after the acquisition. Titan says Damas income and EBIT have been included in the jewellery business from Q4FY26, whereas the separate acquisition liability is excluded from the Titan Company figures on the quarterly consolidated-business slide.

How did Titan’s operating businesses perform excluding the Damas liability?

Titan’s jewellery segment remained the largest contributor to Q2FY27 operating income, reporting ₹17,495 crore, up 24.1% from ₹14,092 crore in Q2FY26. Jewellery EBIT increased 52.7% to ₹2,300 crore and its EBIT margin rose to 13.1% from 10.7%, although this segment includes Titan’s domestic and international jewellery operations as well as Damas after the acquisition.

Watches recorded the fastest EBIT expansion among the named consumer businesses, with Q2FY27 EBIT of ₹412 crore, up 73.1% from ₹238 crore. Its income rose 27.4% to ₹1,881 crore and its margin reached 21.9%, compared with 16.1% a year earlier. EyeCare’s income increased 27.7% to ₹281 crore, while EBIT rose to ₹23 crore from ₹12 crore.

Other Businesses, which comprise Taneira, Fragrances, Women’s Bags and Titan Engineering & Automation Limited, reported income of ₹808 crore, up 45.1% from ₹557 crore. EBIT in that group rose 147% to ₹173 crore, with the margin increasing to 21.4% from 12.6%. These segment figures frame the operating business performance independently of the Damas liability adjustment.

Within domestic jewellery, the Tanishq, Mia, Zoya and beYon portfolio grew about 20% year on year to ₹14,935 crore in Q2FY27. Its domestic quarterly EBIT was ₹2,142 crore at a 14.3% margin, including a one-time customs-duty benefit of ₹490 crore; excluding that benefit, Titan reported normalised EBIT of ₹1,652 crore and an 11.1% margin.

Why can Titan’s Damas liability change again before CY29?

Titan says the option liability must be fair-valued at every reporting date through CY29, so the Q2FY27 ₹671 crore reduction is not presented as final. The company expects subsequent assessments of probable Damas performance to result in either an increase or a decrease in the liability, with a corresponding accounting adjustment in the reported financial statements.

Foreign-exchange revaluation may also affect the liability, if applicable, according to Titan. A later reassessment could therefore reverse part or all of the current credit, or reduce the liability further, without necessarily tracking the quarterly movement in Titan’s core operating income or EBIT.

The present reassessment specifically stems from CY26 performance being affected by Middle East geopolitical conditions. Titan does not give a quantified Damas revenue, EBIT or milestone outcome in the supplied presentation, so the document does not establish how much of the ₹671 crore reduction is attributable to a particular market, product category or forecast period.

The company’s half-year operating figures also continue to exclude the acquisition liability. For the first half of FY27, or H1FY27, Titan reported total income of ₹41,286 crore, up 32.4% from ₹31,186 crore, and EBIT of ₹5,647 crore, up 59.1% from ₹3,550 crore. The stated H1FY27 EBIT margin was 13.7%, compared with 11.4% in H1FY26.

Conclusion

The Damas revaluation means Titan’s Q2FY27 reported financial statements contain a ₹671 crore non-operational credit arising from a lower estimate of the future payment for the remaining 33% Damas stake. It is distinct from the company’s disclosed operating view, where Q2FY27 income rose to ₹20,533 crore and EBIT rose to ₹2,865 crore, both excluding the acquisition liability.

The next item to watch is Titan’s quarterly fair-value reassessment of the Damas option liability through CY29, when the milestone-linked second tranche is due after the stated period. Management has said future changes in probable Damas performance and any applicable foreign-exchange revaluation can increase or decrease the liability, making subsequent reported-account adjustments possible.